Altria Applies to FDA for Selling NJOY Fruit Flavors in 100,000 Stores by 2024

Business by 2FIRSTS.ai
Feb.23.2024
Altria Applies to FDA for Selling NJOY Fruit Flavors in 100,000 Stores by 2024
Tobacco company Altria plans to introduce berry and watermelon flavored e-cigarettes, implementing bluetooth technology to restrict underage use.

According to Bloomberg's report on February 21st, the American tobacco company Altria stated that they have methods to ensure that when looking for new alternatives to tobacco products, these products are only suitable for adults.

 

CEO Billy Gifford recently announced at a meeting that Altria is finalizing its application to the Food and Drug Administration to sell NJOY e-cigarette products in blueberry and watermelon flavors. He mentioned that Altria is awaiting FDA feedback on the mint-flavored version.

 

The company plans to use Bluetooth technology to prevent minors from using it, but the specific method has not been detailed yet. Gifford stated, "We have proven that age restrictions can effectively prevent minors from accessing in almost all cases."

 

Gifford stated that Altria plans to introduce its regular tobacco-flavored NJOY e-cigarette products to 100,000 stores by 2024, up from last year's approximately 75,000 stores, and will adopt new packaging. He estimates that the international sales opportunities for heated tobacco and e-cigarette products are worth between $35 billion and $50 billion.

 

After achieving encouraging results with the launch of the larger sized oral nicotine pouch On! Plus, Altria plans to expand sales in Sweden and also introduce the product in the UK.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai
Singapore Cracks Down on Vaping: Over 3,700 Offenders Caught Between April and June
Singapore Cracks Down on Vaping: Over 3,700 Offenders Caught Between April and June
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) announced that more than 3,700 people were caught and fined for possessing or using vapes between April and June 2024, marking a nearly 20% increase from the previous quarter. Authorities have intensified enforcement at military camps, training schools, and border checkpoints, while imposing tougher actions on cases involving “Kpods” laced with etomidate.
Aug.27 by 2FIRSTS.ai
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
E-cigarette sellers and buyers asked the Eighth Circuit Court to keep blocking Iowa's HF 2677 bill. The bill would make all e-cigarettes sold in Iowa get FDA approval. They say the federal Food, Drug, and Cosmetic Act blocks this law, as it steps on FDA's toes by adding penalties where FDA didn't act. If the bill goes through, businesses might close and people could lose tools to quit smoking.
Aug.28 by 2FIRSTS.ai
Singapore's Narcotics Bureau cracked down on a criminal group smuggling etomidate-containing e-cigarettes for the first time, arresting 8 people and seizing a large number of cartridges
Singapore's Narcotics Bureau cracked down on a criminal group smuggling etomidate-containing e-cigarettes for the first time, arresting 8 people and seizing a large number of cartridges
CNB launches first major operation against e-liquid smuggling group in Singapore, arresting 7 men and 1 woman.
Sep.15 by 2FIRSTS.ai
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian police have busted a criminal syndicate distributing the new-type drug MDMA and seized e-cigarette vape oil and related items worth approximately RM1.48 million (about USD 352,000). Nine suspects were arrested, including a Thai woman. The case is being investigated under Section 39B of the Dangerous Drugs Act.
Aug.29 by 2FIRSTS.ai
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
At the 2025 Barclays Global Consumer Conference, Philip Morris International's CEO said that strong summer sales of IQOS and ZYN will boost the company's full-year 2025 adjusted EPS by 13% to 15%, the best performance since 2011 (excluding pandemic recovery). He also noted that IQOS has maintained strong growth in Q3, with ZYN sales up about 32% in the first eight weeks. The full-year shipment volume is expected to be between 800 million and 840 million cans.
Sep.03 by 2FIRSTS.ai